Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Human immunodeficiency virus (HIV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Human immunodeficiency virus (HIV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Human immunodeficiency virus (HIV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 321 of 321 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Height | Weight | Menopausal Status | Smoking Notes | Symptoms | HIV IFA | dHIV S/CO | Last Positive HIV Test | Currently Taking ART | Current Drug Therapy | Co-Infections | Current AIDS Related Symptoms | Diagnostic Status | Acquired Infection Category | Current AIDS Symptoms | Site of Metastasis | History of Benign Disease Prior to Cancer Diagnosis | Clinical Diagnosis | Additional Information | Current Co-Infections | Most Recent CD4 Results | Anti-Retroviral Therapy (ART or HAART) | Previous Drug Therapy | HIV-1/2 Ag/Ab Combo Immunoassay | HIV-1/HIV-2 Antibody Differentiation Immunoassay | HIV-1 Ag/Ab Test Performed? | HIV-1 Ag/Ab Test Result | HIV-1 Ag/Ab Test Date | HIV-1 Ag/Ab Test Assay Name | HIV-1 CD4+ (Cell/mm3) Count Test Result | HIV-1 CD4+ Test Date | Date of Freeze | HIV Test Results | Drug Resistance Testing | Abbott Murex HBsAg Version 3 | Abbott Murex Anti-HCV version 4.0 | Co-Infection | Immunoblot | Prism | Elisa | Innolia | DGV | Western Blot INTS | Elisa 2 | Western Blot | Genotype | Detail confirmation | Comments | Serotype | Titer | Titer Detail confirmation | Clinical Presentation | Secondary Viral Infection | Previous Exposure History | Additional Testing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACDA000-BY900044471102012DD | Human immunodeficiency virus (HIV) | United States | ACD-A | 1.00 | 1.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 20-Oct-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | Special Order. Please Inquire | Unknown | Positive | 17.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105690111715DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 23 years 20-Sep-94 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105691111115DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 1.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 6 years 7-Jun-09 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105692111215DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 13-May-13 | Yes | AZT; TDF; 3TC | None | Fever over one month | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900458273021121D1 | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $100.00 | 17 Y | Male | Non-Hispanic | <-70C | 11-Feb-21 | Abbott Architect | CMIA | Viral load >10,000,000 CD4 Abs 145 | Viral load >10,000,000 CD4 Abs 145 | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900458274021221D1 | Human immunodeficiency virus (HIV) | United States | Serum | 2.00 | 1.00 | $100.00 | 17 Y | Male | Non-Hispanic | <-70C | 12-Feb-21 | Abbott m2000 | RNA RT-PCR | Positive | HIV RNA 1 | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092424081618DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 16-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1356 cells/uL | 16-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092425081418DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 68 Y | Male | Non-Hispanic | <-70C | 14-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 266 cells/uL | 23-Mar-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092430081418DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 65 Y | Male | Non-Hispanic | <-70C | 14-Aug-18 | Roche cobas RT-PCR | 30 copies/mL | HIV | Most Recent CD4 Results | 175 cells/uL | 7-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096855071718DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1001 cells/uL | 17-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096856062618DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 44 Y | Male | Non-Hispanic | <-70C | 26-Jun-18 | Roche cobas RT-PCR | 50 copies/mL | HIV | Most Recent CD4 Results | 377 cells/uL | 26-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096861060618DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 47 Y | Male | Non-Hispanic | <-70C | 06-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1084 cells/uL | 6-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096868051518DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 32 Y | Male | Non-Hispanic | <-70C | 15-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 961 cells/uL | 18-Apr-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900097659080118DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 57 Y | Male | Non-Hispanic | <-70C | 01-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 26 cells/uL | 1-Aug-18 | HIV Genotype Testing | Genotype B | 21-Nov-17 | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900109581081318DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 43 Y | Male | Non-Hispanic | <-70C | 13-Aug-18 | Roche cobas RT-PCR | 20 copies/mL | HIV | Most Recent CD4 Results | 1266 cells/uL | 6-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900355600120919DD | Human immunodeficiency virus (HIV) | United States | Serum | 1.00 | 1.00 | $250.00 | 28 Y | Male | Non-Hispanic | <-70C | 09-Dec-19 | Roche cobas Taqman | RT-PCR | 20.00 copies/mL | 2019-11-05 | Most Recent CD4 Results | 582 cells/uL | 5-Nov-19 | $250.00 | Unknown | 2019-12-09 | Yes Genvoya started on 5-Jun-2017 | HIV Seropositive | Sexual Transmission | Syphilis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-CV900098576100416DD | Human immunodeficiency virus (HIV) | Vietnam | Serum | 1.00 | 8.00 | $250.00 | 43 Y | Male | Non-Hispanic | <-70C | 04-Oct-16 | Staging | Tumor N/A; N1 | $250.00 | Unknown | Unknown | Former 20 per day for 10 years | Lymph Nodes | No | Metastatic Carcinoma; HIV | Neck lymph node biopsy: The structure replaced by tumor tissue structures with large nuclear tumor cells, clear nuclear alkaline. Immunohistochemistry staining: tumor cells (+) to marker CK17, negative with remaining markers: CK20, P63, TTTF1, LCA, Napsin, CDX2, S100, HMB45. Conclusion: Gland carcinoma lymph node metastasis. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458834031320D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 64 Y | Male | Non-Hispanic | 13-Mar-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-03-13 | Biktarvy started in 2019 | None | None | 244 cells/uL 4-Feb-2020 | Yes | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458834031320D2 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 2.00 | $110.00 | 64 Y | Male | Non-Hispanic | 13-Mar-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-03-13 | Biktarvy started in 2019 | Sexual Transmission | None | 244 cells/uL 4-Feb-2020 | Yes | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458835021920D2 | Human immunodeficiency virus (HIV) | United States | Serum | 3.00 | 2.00 | $110.00 | 58 Y | Male | Non-Hispanic | 19-Feb-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-02-19 | Biktarvy started in Jan-2020 | Sexual Transmission | None | 650 cells/uL 5-Feb-2020 | Yes | Norvir and Prezista ended in Jan-2020 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458836021720D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 1.00 | $110.00 | 66 Y | Male | Non-Hispanic | 17-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-17 | Triumeq started in 2015 | None | Hepatitis C | 812 cells/uL 10-Jan-2020 | Yes | Prezcobix, Viread ended in 2015 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458836021720D2 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 66 Y | Male | Non-Hispanic | 17-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-17 | Triumeq started in 2015 | Sexual Transmission | Hepatitis C | 812 cells/uL 10-Jan-2020 | Yes | Prezcobix, Viread ended in 2015 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458838010620D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 1.00 | $110.00 | 22 Y | Female | Non-Hispanic | 06-Jan-20 | Cobas AmpliPrep Taqman | 1218 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | None currently. Will start new therapy 9-Jan-2020 but not sure which one | None | None | 258 cells/uL 17-Dec-2019 | No | Truvada, Norvir and Prezista started in 2016. History of non-compliance | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458839020520D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 55 Y | Male | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 7530 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Tivicay, Truvada and Prezcobix started in 2013 | None | None | 449 cells/uL 14-Jan-2020 | Yes | Truvada, Norvir and Prezcobix ended in 2013. | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458839020520D2 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 55 Y | Male | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 7530 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Tivicay, Truvada and Prezcobix started in 2013 | Sexual Transmission | None | 449 cells/uL 14-Jan-2020 | Yes | Truvada, Norvir and Prezcobix ended in 2013. | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458840120319D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 50 Y | Female | Non-Hispanic | 03-Dec-19 | Unknown Manufacturer | 39 copies/mL | HIV | $110.00 | Unknown | 2019-12-03 | No | N/A | N/A | N/A | 437 cells/uL | 5-Sep-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458842111919D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 56 Y | Female | Non-Hispanic | 19-Nov-19 | Roche Taqman Assay v2.0 | 82 copies/mL | HIV | $110.00 | Unknown | 2019-11-19 | No | N/A | N/A | N/A | 260.10 cells/mcL | 26-Jul-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458843021120D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 1.00 | $110.00 | 22 Y | Male | Hispanic | 11-Feb-20 | Cobas AmpliPrep Taqman | 43862 copies/mL | HIV | $110.00 | Unknown | 2020-02-11 | Triumeq started in 2017 | None | None | 422 cells/uL 21-Jan-2020 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458844013020D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 1.00 | $110.00 | 30 Y | Male | Hispanic | 30-Jan-20 | Unknown Manufacturer | 56 copies/mL | HIV | $110.00 | Unknown | 2020-01-30 | Descovy & Tivicay started in Oct-2016 | None | Hepatitis C | 670 cells/uL 21-Jan-2020 | No | Norvir, Truvada & Reyataz ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458845112019D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 70 Y | Male | Non-Hispanic | 20-Nov-19 | Unknown Manufacturer | 26 copies/mL | HIV | $110.00 | Unknown | 2019-11-20 | No | N/A | N/A | N/A | 290 cells/uL | 12-Sep-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458846010720D1 | Human immunodeficiency virus (HIV) | United States | Serum | 2.00 | 1.00 | $110.00 | 54 Y | Female | Non-Hispanic | 07-Jan-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-01-07 | Biktarvy started Dec-2018 | None | None | 618 cells/uL 1-Nov-2019 | No | Atripla from 2011-2018 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458848012220D1 | Human immunodeficiency virus (HIV) | United States | Serum | 2.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 22-Jan-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-01-22 | Juluca started in 2018 | None | None | 595 cells/uL 11-Nov-2019 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458849022720D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 1.00 | $110.00 | 44 Y | Male | Hispanic | 27-Feb-20 | Unknown Manufacturer | 60 copies/mL | HIV | $110.00 | Unknown | 2020-02-27 | Biktarvy started in 2019 | None | None | 689 cells/uL 13-Feb-2020 | Yes | Complera ended in 2019; Genvoya ended in 2018; Atripla ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458849022720D2 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 2.00 | $110.00 | 44 Y | Male | Hispanic | 27-Feb-20 | Unknown Manufacturer | 60 copies/mL | HIV | $110.00 | Unknown | 2020-02-27 | Biktarvy started in 2019 | Sexual Transmission | None | 689 cells/uL 13-Feb-2020 | Yes | Complera ended in 2019; Genvoya ended in 2018; Atripla ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458850021220D1 | Human immunodeficiency virus (HIV) | United States | Serum | 3.00 | 2.00 | $110.00 | 63 Y | Female | Non-Hispanic | 12-Feb-20 | Unknown Manufacturer | 80 copies/mL | HIV | $110.00 | Unknown | 2020-02-12 | None | None | Hepatitis C | 1659 cells/uL 24-Jan-2020 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458850021220D2 | Human immunodeficiency virus (HIV) | United States | Serum | 3.00 | 2.00 | $110.00 | 63 Y | Female | Non-Hispanic | 12-Feb-20 | Unknown Manufacturer | 80 copies/mL | HIV | $110.00 | Unknown | 2020-02-12 | None | IV Drug Abuse | Hepatitis C | 1659 cells/uL 24-Jan-2020 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458851020520D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 62 Y | Female | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Triumeq started about 5 or 6 years ago | None | None | 594 cells/uL 23-Jan-2020 | Yes | Kaletra - Doesn't recall end date | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458851020520D2 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 62 Y | Female | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Triumeq started about 5 or 6 years ago | Sexual Transmission | None | 594 cells/uL 23-Jan-2020 | Yes | Kaletra - Doesn't recall end date | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458852020620D1 | Human immunodeficiency virus (HIV) | United States | Serum | 3.00 | 2.00 | $110.00 | 55 Y | Male | Non-Hispanic | 06-Feb-20 | Unknown Manufacturer | 2250 copies/mL | HIV | $110.00 | Unknown | 2020-02-06 | Evotaz and Abacavir started in 2016 | None | None | 1091 cells/uL 22-Jan-2020 | Yes | Reyataz, Norvir and Epivir ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458852020620D2 | Human immunodeficiency virus (HIV) | United States | Serum | 3.00 | 2.00 | $110.00 | 55 Y | Male | Non-Hispanic | 06-Feb-20 | Unknown Manufacturer | 2250 copies/mL | HIV | $110.00 | Unknown | 2020-02-06 | Evotaz and Abacavir started in 2016 | Sexual Transmission | None | 1091 cells/uL 22-Jan-2020 | Yes | Reyataz, Norvir and Epivir ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458853121619D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 1.00 | $110.00 | 36 Y | Female | Non-Hispanic | 16-Dec-19 | Unknown Manufacturer | 503 copies/mL | HIV | $110.00 | Unknown | 2019-12-16 | No | N/A | N/A | N/A | 613 cells/uL | 2019-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458854031120D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 2.00 | $110.00 | 61 Y | Male | Non-Hispanic | 11-Mar-20 | Unknown Manufacturer | 50 copies/mL | HIV | $110.00 | Unknown | 2020-03-11 | Prezcobix and Tivicay started in 2012 | None | Hepatitis C | 326 cells/uL 27-Jan-2020 | Yes | Kaletra and Truvada ended in 2012 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458854031120D2 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 2.00 | $110.00 | 61 Y | Male | Non-Hispanic | 11-Mar-20 | Unknown Manufacturer | 50 copies/mL | HIV | $110.00 | Unknown | 2020-03-11 | Prezcobix and Tivicay started in 2012 | Sexual Transmission | Hepatitis C | 326 cells/uL 27-Jan-2020 | Yes | Kaletra and Truvada ended in 2012 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458855121819D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 2.00 | $110.00 | 57 Y | Male | Non-Hispanic | 18-Dec-19 | Roche Taqman Assay v2.0 | 107 copies/mL | HIV | $110.00 | Unknown | 2019-12-18 | No | N/A | N/A | N/A | 268 cells/uL | 2019-10-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458856010620D1 | Human immunodeficiency virus (HIV) | United States | Serum | 4.00 | 1.00 | $110.00 | 18 Y | Male | Non-Hispanic | 06-Jan-20 | Unknown Manufacturer | 68200 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | Biktarvy started 22-Nov-2019 | None | None | 453 cells/uL 13-Nov-2019 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-FI900458857121619D1 | Human immunodeficiency virus (HIV) | United States | Serum | 5.00 | 2.00 | $110.00 | 50 Y | Male | Non-Hispanic | 16-Dec-19 | Unknown Manufacturer | 180 copies/mL | HIV | $110.00 | Unknown | 2019-12-16 | Yes | Reactive | 43726 | HIV Screen 4th Generation wRfx | 1,305 cells/uL | 2019-09-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387801012020DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 38 Y | Male | Non-Hispanic | <70C | 20-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387813022720DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <70C | 27-Feb-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387814022720DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <70C | 27-Feb-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387815011420DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 22 Y | Male | Non-Hispanic | <70C | 14-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387837011520DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 38 Y | Male | Non-Hispanic | <70C | 15-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900387838021420DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 20 Y | Male | Non-Hispanic | <70C | 14-Feb-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900388247020420DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 26 Y | Female | Non-Hispanic | <70C | 04-Feb-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900388248011520DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 26 Y | Male | Non-Hispanic | <70C | 15-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900388249012920DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 31 Y | Male | Non-Hispanic | <70C | 29-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-G2900388292012920DD | Human immunodeficiency virus (HIV) | Ukraine | Serum | 0.70 | 1.00 | Special Order. Please Inquire | 28 Y | Male | Non-Hispanic | <70C | 29-Jan-20 | DIA - HIV - p24 | ELISA | Positive | HIV P24 Ag | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900086472033017DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 2.00 | 1.00 | $100.00 | 41 Y | Female | Non-Hispanic | <-70C | 30-Mar-17 | Abbott Architect | Negative | HIV | $100.00 | Unknown | 4/14/2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900086474032917DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 2.25 | 1.00 | $100.00 | 19 Y | Female | Non-Hispanic | <-70C | 29-Mar-17 | Abbott Architect | Negative | HIV | $100.00 | Unknown | 4/14/2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028135051418DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 57 Y | Female | Non-Hispanic | <-70C | 14-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 637 cells/uL | 14-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028142053118DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 45 Y | Male | Non-Hispanic | <-70C | 31-May-18 | Roche cobas RT-PCR | 60 copies/mL | HIV | Most Recent CD4 Results | 769 cells/uL | 31-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033071073018DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 50 Y | Female | Non-Hispanic | <-70C | 30-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 922 cells/uL | 30-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033073051518DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 456 cells/uL | 15-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | IV Drug Abuse | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033081060618DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 06-Jun-18 | Roche cobas RT-PCR | 32070 copies/mL | HIV | Most Recent CD4 Results | 493 cells/uL | 6-Jun-18 | HIV Genotype Testing | Genotype B | 10-Aug-16 | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084640092513DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 46 Y | Male | Unknown | <-70C | 25-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 800 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084649100113DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 48 Y | Male | Non-Hispanic | <-70C | 01-Oct-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 1,239 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084652110713DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 48 Y | Male | Non-Hispanic | <-70C | 07-Nov-13 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 1084 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084656011515DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 66 Y | Male | Non-Hispanic | <-70C | 15-Jan-15 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 477 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041713120814DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 46 Y | Female | Non-Hispanic | < -70C | 08-Dec-14 | Siemens Trugene | No resistance | 4-Aug-14 | Beckman Coulter CD4 Result | 256 | 4-Aug-14 | Roche Amplicor RT-PCR | 28,108 cps/mL | 4-Aug-14 | $250.00 | Unknown | No | N/A | HIV Seropositive | Sexual Transmission | Lymphadenopathy 4-Aug-2014 Microcytic anemia 04-Dec-2014 | Last Positive Test 22-Jun-2008 Test - Western Blot Subject seropositive 6 years | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041715020515DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 38 Y | Male | Non-Hispanic | < -70C | 05-Feb-15 | Siemens Trugene | RT-V106I, PR-M36I | 22-Jan-13 | Beckman Coulter CD4 Result | 106 | 14-Jan-15 | Most Recent Viral Load (Roche Amplicor) | 34,500 copies/mL | 14-Jan-15 | $250.00 | Unknown | 21-Jan-13 Test -Oraquick; Subject seropositive 2 years | Yes; Truvada, Ritonavir | Hep A +; Syphilis; Disseminated Pulmonary MAC 2015; 2013; 2013 | HIV Seropositive; AIDS | Sexual Transmission | Yes; Abnormal U/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900047479022315DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 51 Y | Male | Non-Hispanic | <-70C | 23-Feb-15 | Siemens Trugene | RT-D67N, K70R, V90I, K103N, V108I, M184V, K219E, P225H | 3-Mar-11 | CD4 result | 538 cells/uL | Most Recent Viral Load (Roche Amplicor) | 204 copies/mL | 25-Nov-14 | $250.00 | Unknown | Seropositive for 14 years 6-Apr | Yes Stribild | HCV 1a; VL 22,663,488; HAV + | HIV Seropositive | Transfusion | Neuropathy - HIV vs DM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900047480031215DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 12-Mar-15 | Siemens Trugene | RT-K103N, M41L | 9-Jan-14 | CD4 result | 48 cells/uL | Most Recent Viral Load (Roche Amplicor) | 116,613 copies/mL | 5-Feb-15 | $250.00 | Unknown | Seropositive for 7 years 6-Aug-08 | Yes Atazanavir; Truvada; Norvir | STI - Trep. Pall > 8.0 + | HIV Seropositive AIDS | Sexual Transmission | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900066358121514DD | Human immunodeficiency virus (HIV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 49 Y | Male | Non-Hispanic | < -70C | 15-Dec-14 | Siemens Trugene | No mutations | 6-Aug-14 | Beckman Coulter CD4 Result | 72 | 22-Jan-14 | Roche Amplicor RT-PCR | 34,817 cps/mL | 6-Aug-14 | $250.00 | Unknown | No | Hepatitis C 30-Oct-2013 Stable | HIV Seropositive | IV Drug Abuse | No | Last Positive Test 20-Sep-2011 Test - Unknown Subject seropositive 3 years (from prison record) (patient says since 2002) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108103110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 42 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | 5,970 copies/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108105110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 28 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | 307 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108227110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 25 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108228110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 24 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108229110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 4.00 | $50.00 | 19 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036057102209DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 31 Y | Male | Unknown | <-70°C | 22-Oct-09 | Abbott Prism | 86 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036058051410DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 28 Y | Female | Unknown | <-70°C | 14-May-10 | Abbott Prism | 140 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036059063010DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 61 Y | Male | Unknown | <-70°C | 30-Jun-10 | Abbott Prism | 162 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | Syphilis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036060081710DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 32 Y | Male | Unknown | <-70°C | 17-Aug-10 | Abbott Prism | 136 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036061090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 40 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 162 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036062090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 34 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 82 S/Co | HIV | Immunoblot | gp120(+/-) gp41(2+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036063090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 22 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 153 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036065120710DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 21 Y | Male | Unknown | <-70°C | 07-Dec-10 | Abbott Prism | 104 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036066121110DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 46 Y | Male | Unknown | <-70°C | 11-Dec-10 | Abbott Prism | 128 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036067012611DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 29 Y | Male | Unknown | <-70°C | 26-Jan-11 | Abbott Prism | 94 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036068020311DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 23 Y | Male | Unknown | <-70°C | 03-Feb-11 | Abbott Prism | 70 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036070032511DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 48 Y | Male | Unknown | <-70°C | 25-Mar-11 | Abbott Prism | 153 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060022072111DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 24 Y | Female | Unknown | <-70°C | 21-Jul-11 | Abbott Prism | 126 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060023092711DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 27-Sep-11 | Abbott Prism | 9.58 S/Co | HIV | Immunoblot | gp120(-) gp41(2+) 2ENV(-) p31(-) p24(+/-) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060024110911DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 09-Nov-11 | Abbott Prism | 150 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060025120511DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 05-Dec-11 | Abbott Prism | 96 S/Co | Co-Infection | Syphilis | $50.00 | Unknown | gp120(4+) gp41(4+) 2ENV(-) p31(3+) p24(4+) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060026011312DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 45 Y | Male | Unknown | <-70°C | 13-Jan-12 | Abbott Prism | 111 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060027012812DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 42 Y | Male | Unknown | <-70°C | 28-Jan-12 | Abbott Prism | 98 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060028013112DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 31 Y | Male | Unknown | <-70°C | 31-Jan-12 | Abbott Prism | 49 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060029022312DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 50 Y | Female | Unknown | <-70°C | 23-Feb-12 | Abbott Prism | 90 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066322022512DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 25-Feb-12 | Abbott Prism | 92 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066323022912DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 42 Y | Male | Unknown | <-70°C | 29-Feb-12 | Abbott Prism | 86 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(-) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066324030212DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 02-Mar-12 | Abbott Prism | 84 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066325040412DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 38 Y | Male | Unknown | <-70°C | 04-Apr-12 | Abbott Prism | 116 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066326051012DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 10-May-12 | Abbott Prism | 84 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066327050712DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 24 Y | Female | Unknown | <-70°C | 07-May-12 | Abbott Prism | 121 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066328053112DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 31-May-12 | Abbott Prism | 131 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066329060712DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 35 Y | Female | Unknown | <-70°C | 07-Jun-12 | Abbott Prism | 119 S/Co | HIV | Immunoblot | Gp120(3+) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066330070912DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 09-Jul-12 | Abbott Prism | 136 S/Co | HIV | Immunoblot | sgp120(3+) gp41(3+) p31(2+) p24(3+) p17(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066332112012DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 20-Nov-12 | Abbott Prism | 80.37 S/Co | HIV | Immunoblot | sgp120(2+) gp41(3+) p31(2+) p24(2+) p17(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066396051107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 34 Y | Male | Unknown | <-70°C | 11-May-07 | Abbott Prism | 16.88 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(+/-) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066397051807DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 44 Y | Male | Unknown | <-70°C | 18-May-07 | Abbott Prism | 15.33 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066399032305DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 40 Y | Male | Unknown | <-70°C | 23-Mar-05 | Abbott Prism | 123.23 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066400041107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 25 Y | Male | Unknown | <-70°C | 11-Apr-07 | Abbott Prism | 108.89 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066401121107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 39 Y | Male | Unknown | <-70°C | 11-Dec-07 | Abbott Prism | 132 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066402010808DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 54 Y | Female | Unknown | <-70°C | 08-Jan-08 | Abbott Prism | 72.79 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066404022208DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 22-Feb-08 | Abbott Prism | 99.31 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107002053011DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 30-May-11 | Abbott Prism | 72 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107004060311DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 34 Y | Female | Unknown | <-70°C | 03-Jun-11 | Abbott Prism | 72 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107005061811DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 35 Y | Male | Unknown | <-70°C | 18-Jun-11 | Abbott Prism | 7.55 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107017051911DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Male | Unknown | <-70°C | 19-May-11 | Abbott Prism | 114 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085321090111DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 3.00 | $50.00 | Unknown | < -70C | 01-Sep-11 | Roche cobas | 964 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 149.48 | 12.605 | Positive | Pos | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085322012411DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 24-Jan-11 | Roche cobas | 444 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 11.811 | Positive | Pos | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (2+); p68 (3+); gp120 (3+); gp160 (3+) | 13.246 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900086483052710DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 27-May-10 | Roche cobas | 7,621 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 118.6 | 11.167 | Positive sgp41(4+); gp120 (2+); p31 (2+); p24 (2+); p17 (2+); sgp105 (--); gp36 (--) | Pos | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108431071710DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 17-Jul-10 | Roche cobas | 2,525 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 10.83 | Positive | Pos | 16.043 | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) AgP24 Négatif | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108434101810DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 18-Oct-10 | Roche cobas | 1,152 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 10.563 | Positive | Pos | 14.282 | p18 (2+); p24 (3+); p34 (3+); gp41 (2+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) AgP24 Négatif | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900380829062212D2 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 30.00 | 1.00 | Special Order. Please Inquire | 50 Y | Male | Unknown | <-70C | 22-Jun-12 | Abbott Prism HIV O Plus | 0.49 | HIV Negative | Innolia | 0.01 | Negative | Procleix Ultrio Assay Novartis | Positive | DGV | Special Order. Please Inquire | Unknown | M Subtype CRF02 | Blot : sgp120 (--); gp41 (--); p31 (--); p24 (--); p17 (--); sgp105 (--); gp36 (--) WB INTS : p17(--); p24(+/--); p31(--); gp41(--); p55(--); p66(--); gp120(++); gp160(+++); peptHIV2(--) | Ag P24 POS ratio = 1,32 Do/Vs | Non typable | 102698 copies/mL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900380829062212DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 27.00 | 1.00 | Special Order. Please Inquire | 50 Y | Male | Unknown | <-70C | 22-Jun-12 | Abbott Prism HIV O Plus | 0.49 | HIV Negative | Innolia | 0.01 | Negative | Procleix Ultrio Assay Novartis | Positive | DGV | Special Order. Please Inquire | Unknown | M Subtype CRF02 | Blot : sgp120 (--); gp41 (--); p31 (--); p24 (--); p17 (--); sgp105 (--); gp36 (--) WB INTS : p17(--); p24(+/--); p31(--); gp41(--); p55(--); p66(--); gp120(++); gp160(+++); peptHIV2(--) | Ag P24 POS ratio = 1,32 Do/Vs | Non typable | 102698 copies/mL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900380830041015D2 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 30.00 | 1.00 | Special Order. Please Inquire | 46 Y | Male | Unknown | <-70C | 10-Apr-15 | Abbott Prism HIV O Plus | 0.01 | HIV Negative | Procleix Ultrio Assay Novartis | Positive | DGV | Special Order. Please Inquire | Unknown | M Subtype B | Ag P24 POS ratio = 3,21 Do/Vs | Non typable | 123861 copies/mL | WB INTS : p17(--); p24(--); p31(--); gp41(--); p55(--); p66(--); gp120(--); gp160(--); peptHIV2(--) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900380830041015DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 30.00 | 1.00 | Special Order. Please Inquire | 46 Y | Male | Unknown | <-70C | 10-Apr-15 | Abbott Prism HIV O Plus | 0.01 | HIV Negative | Procleix Ultrio Assay Novartis | Positive | DGV | Special Order. Please Inquire | Unknown | M Subtype B | Ag P24 POS ratio = 3,21 Do/Vs | Non typable | 123861 copies/mL | WB INTS : p17(--); p24(--); p31(--); gp41(--); p55(--); p66(--); gp120(--); gp160(--); peptHIV2(--) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900410099012015DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 25.00 | Special Order. Please Inquire | 27 Y | Male | Unknown | <-70C | 20-Jan-15 | Abbott Prism HIV O Plus | 66 | HIV Positive | HIV Combo Architect Abbott | 11.41 | Positive | Procleix Ultrio Assay Novartis | Positive | DGV | Special Order. Please Inquire | Unknown | M Subtype B | InnoLia EFS : sgp120(-) ; gp41(3+); p31(-) p24(2+) ; p17(+) ; sgp105(-) gp36(-)// | Ag P24 POS ratio = 1,30 do/vs | Non typable | 27398 copies/mL | WB INTS : p17(+/-); p24(2+); p31(--); gp41(tr); p55(--); p66(--); gp120(2+); gp160(3+); peptHIV2(--) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038160053012DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 23 Y | Male | Hispanic | <-70C | 30-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 21.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038162013114DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 30 Y | Female | Non-Hispanic | <-70C | 31-Jan-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 78.9 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 86.83 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 85.43 | $100.00 | Unknown | Not Tested | 21.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038163042413DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 19 Y | Male | Non-Hispanic | <-70C | 24-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 27.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044470061114DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 21 Y | Male | Hispanic | <-70C | 11-Jun-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 135.63 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 112.69 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 107.99 | $100.00 | Unknown | Not Tested | 21.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044472040412DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 34 Y | Male | Non-Hispanic | <-70C | 04-Apr-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 9.623 | $100.00 | Unknown | Positive | 28.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044473030412DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 54 Y | Female | Hispanic | <-70C | 04-Mar-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 29.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044474032613DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 1.00 | $100.00 | 51 Y | Female | Non-Hispanic | <-70C | 26-Mar-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 27.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044476041213DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 2.00 | $100.00 | 49 Y | Male | Non-Hispanic | <-70C | 12-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 0.62 (NR) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044477072614DD | Human immunodeficiency virus (HIV) | United States | CP2D | 1.00 | 2.00 | $100.00 | 40 Y | Male | Unknown | <-70C | 26-Jul-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 123.82 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 131.55 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 125.95 | $100.00 | Unknown | Not Tested | 22.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032290111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 17-Oct-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032826111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 11-May-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032828111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 7-May-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032829111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 8 years 10-Jun-07 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032830111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 33 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 10-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032831111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 14-Mar-15 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032832111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 17-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032833111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 11-Sep-13 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032834111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 35 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 3 years 20-Aug-12 | Yes | AZT; TDF; 3TC | Skin Rash | Disseminated skin rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036805111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 20 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Jul-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036806111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 20-Jul-14 | Yes | AZT; TDF; 3TC | Diarrhea | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036807111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 42 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 15 years 13-Jul-00 | Yes | AZT; TDF; 3TC | Diarrhea | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036808111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 45 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Jul-15 | Yes | AZT; TDF; 3TC | Tuberculosis | Unexplained loss of weight over 10% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036809111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 24 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 17-Aug-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036810111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 20 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 16-Sep-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036811111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 20-Dec-13 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036812111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 12-Jan-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036814111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $100.00 | 18 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $100.00 | Unknown | STAT-PACK; Seropositive New Case 12-Nov-15 | No | Panadol; Amoxyl | Skin Rash | Herpes Simplex | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042615111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 14-Aug-15 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042616111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 10-Nov-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042619111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 33 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 12-Nov-15 | No | Coartem; Panadol | Respiratory Tract Infection | Unexplained loss of weight and fever for over 1 month | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042620111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 38 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 10-Jun-13 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042621111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 4-Jul-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042622111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 11-Nov-15 | No | None | Tuberculosis | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042623111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 20-Apr-15 | Yes | Septrin; AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042624111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 42 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 6 years 4-Jun-09 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042625111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Oct-15 | Yes | Septrin; Amoxyl; AZT; TDF; 3TC | Cough | Herpes Zoster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042626111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 14-Apr-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046324111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 30 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Apr-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046327111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 24 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 14-Aug-13 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046328111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 20-Feb-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046334111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 11-Nov-15 | No | None | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046335111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 38 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 10-Feb-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046336111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 35 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 12-Jun-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046337111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 27 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 11-Jul-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046338111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 21-Apr-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079015111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 31 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 3 years 20-Aug-12 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079016111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 21 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 16-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079017111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 19 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 20-Jul-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079018111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 2-Mar-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079019111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 30 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 2-Jan-14 | Yes | AZT; TDF; 3TC | Respiratory Tract Infection | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079020111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 4-Jun-15 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080479110119DD | Human immunodeficiency virus (HIV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $250.00 | 27 Y | Female | Hispanic | < -70C | 01-Nov-19 | Roche Amplicor | 8,530 copies/mL | HIV | $250.00 | Unknown | Efavirenz, Truvada, Omeprazole | 62.99 | 94 | None | Cervical Dysplasia | HPV | Sexual Contact | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080480110119DD | Human immunodeficiency virus (HIV) | Mexico | Double Spun Plasma | 1.00 | 8.00 | $250.00 | 23 Y | Female | Hispanic | < -70C | 01-Nov-19 | Roche Amplicor | <40 copies/mL | HIV | $250.00 | Unknown | INH (Isoniazid) 300 mg/day | 66.54 | 152 | Asymptomatic | Asymptomatic; CD4 count - 540 | Genital HPV | Sexual Contact | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080481110119DD | Human immunodeficiency virus (HIV) | Mexico | Double Spun Plasma | 1.00 | 7.00 | $250.00 | 37 Y | Male | Hispanic | < -70C | 01-Nov-19 | Viral Load | Not Detected | HIV | $250.00 | Unknown | INH (Isoniazid), Rifampin, Ethambutol, PZA | 66.93 | 147 | Intestinal HPV, Oral Candida, Genital Worts | Intestinal TB | HPV | Sexual Contact | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039983012710DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 27-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 753 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039984020910DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 44 Y | Male | Non-Hispanic | <-70C | 09-Feb-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 550 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039985030810DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 41 Y | Male | Non-Hispanic | <-70C | 08-Mar-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 529 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039986031010DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 45 Y | Male | Unknown | <-70C | 10-Mar-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 2083 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039987042010DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 56 Y | Male | Non-Hispanic | <-70C | 20-Apr-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 504 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039988060810DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 41 Y | Male | Non-Hispanic | <-70C | 08-Jun-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 520 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039989112910DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 42 Y | Male | Non-Hispanic | <-70C | 29-Nov-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 735 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039990021111DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 11-Feb-11 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 658 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039991041411DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.25 | 2.00 | $100.00 | 46 Y | Male | Non-Hispanic | <-70C | 14-Apr-11 | Chiron 1st Generation | 40 copies/mL | HIV | CD4 Result | 729 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039992041411DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 4.00 | $50.00 | 64 Y | Male | Non-Hispanic | <-70C | 14-Apr-11 | Roche Ultrasensitive | HIV | CD4 Result | 498 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039993060911DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 4.00 | $50.00 | 59 Y | Male | Non-Hispanic | <-70C | 09-Jun-11 | Chiron 3.0 | HIV | CD4 Result | 390 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084658010510DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 54 Y | Male | Non-Hispanic | <-70C | 05-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 702 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084659011910DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 59 Y | Female | Non-Hispanic | <-70C | 19-Jan-10 | Roche Ultrasensitive | 257 copies/mL | HIV | CD4 Result | 672 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084660012010DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 4.00 | $50.00 | 50 Y | Male | Non-Hispanic | <-70C | 20-Jan-10 | Chiron 3.0 | HIV | CD4 Result | 683 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900038161080112DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 22 Y | Male | Unknown | <-70C | 01-Aug-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | NAT R but QNS for discrim testing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900044459050812DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Male | Non-Hispanic | <-70C | 08-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 9.939 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | >10.000 | $50.00 | Unknown | Positive | 23.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900044475060313DD | Human immunodeficiency virus (HIV) | United States | Double Spun Plasma | 1.00 | 1.00 | $50.00 | 21 Y | Male | Non-Hispanic | <-70C | 03-Jun-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | >10.000 | $50.00 | Unknown | Positive | 32.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032221012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 46 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032226012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 33 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032227012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 37 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032228012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 40 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032229012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 37 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032230012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 40 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032231012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 36 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032232012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 32 Y | Female | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032233012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 38 Y | Female | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032234012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 46 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032235012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 28 Y | Female | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900032236012015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 0.60 | 1.00 | $100.00 | 32 Y | Male | Non-Hispanic | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033321042415DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 35 Y | Male | Non-Hispanic | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033322012115DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 30 Y | Female | Non-Hispanic | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033323012115DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 45 Y | Male | Non-Hispanic | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033324012915DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 43 Y | Female | Non-Hispanic | <-70C | 29-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033325012915DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | Male | Non-Hispanic | <-70C | 29-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033326013015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 48 Y | Male | Non-Hispanic | <-70C | 30-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033327013015DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 30 Y | Female | Non-Hispanic | <-70C | 30-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033331012315DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 36 Y | Female | Non-Hispanic | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033332012315DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 42 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033333012315DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033334012315DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900033335012315DD | Human immunodeficiency virus (HIV) | Vietnam | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 36 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900047254020117DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 13 Y | Female | Non-Hispanic | <-70C | 01-Feb-17 | Abbott M2000 RT-PCR | Not Detected | 1-Feb-17 | Most Recent CD4 Results | 998 cells/uL | 10-Jan-17 | 5-Mar-03 | Seropositive 13 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900047255011117DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $100.00 | 12 Y | Female | Non-Hispanic | <-70C | 11-Jan-17 | Abbott M2000 RT-PCR | 998 copies/mL | 11-Jan-17 | Most Recent CD4 Results | 907 cells/?L | 30-Nov-16 | 10-Dec-06 | Seropositive 12 years | $100.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053117110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 31 Y | Male | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 1-Sep-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053119110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 42 Y | Male | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 15-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053120102716DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 27-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 950 cells/uL | 11-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053122102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 30 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 808 cells/uL | 22-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053131110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 39 Y | Female | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 30-Aug-16 | $250.00 | Unknown | Yes | AZT; 3TC; ABC | None | No | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053132102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 22-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053133102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 692 cells/uL | 1-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061912102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 207 cells/uL | 28-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061913102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 565 cells/uL | 27-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061915102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 333 cells/uL | 23-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061916102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 29 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 508 cells/uL | 26-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061917102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 45 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 203 cells/uL | 15-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061919102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 43 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 1-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061921102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 879 cells/uL | 28-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061923102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 40 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 998 cells/uL | 16-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111007110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 370 cells/uL | 24-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111008102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 19 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 23-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874113016DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 30-Nov-16 | Abbott M2000 RT-PCR | 869 copies/mL | 30-Nov-16 | Most Recent CD4 Results | 907 cells/?L | 2-Sep-16 | 11-Apr-08 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874122116DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 21-Dec-16 | Abbott M2000 RT-PCR | 1001 copies/mL | 21-Dec-16 | Most Recent CD4 Results | 520 cells/?L | 29-Nov-16 | 3-Jan-06 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037229111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 49 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037235111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 21 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 15 days | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037237111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 45 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 22 years | Yes | Atazanavir; Kivexa; Norvir | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037238111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 45 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | Yes | Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037240111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 31 Y | Female | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 4 years | Yes | Kaletra; Kivexa | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900041916111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 38 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 3 years | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900043904111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | Yes | Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900066967111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 40 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 4 years | Yes | Atazanavir; Ritonavir; Truvada | None | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036425040717DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 48 Y | Male | Non-Hispanic | <-70C | 07-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 7-Apr-17 | Most Recent CD4 Results | 509 cells/uL | 7-Apr-17 | $250.00 | Unknown | Yes | Genvoya | None | No | HIV Seropositive (10 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036426032917DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 65 Y | Male | Non-Hispanic | <-70C | 29-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 5-Aug-16 | Most Recent CD4 Results | 1111 cells/uL | 29-Mar-17 | $250.00 | Unknown | Yes | Sustiva Epzicom | None | No | HIV Seropositive (14 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036429041217DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 12-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 12-Apr-17 | Most Recent CD4 Results | 324 cells/uL | 12-Apr-17 | $250.00 | Unknown | Yes | Atripla | None | No | HIV Seropositive (6 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049926032117DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 47 Y | Female | Non-Hispanic | <-70C | 21-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 444 cells/uL | 21-Mar-17 | $250.00 | Unknown | Yes | Genvoya; Previously Atripla | None | No | HIV Seropositive (10 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049929052317DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 59 Y | Female | Non-Hispanic | <-70C | 23-May-17 | Roche cobas RT-PCR | <20 copies/mL | 23-May-17 | Most Recent CD4 Results | 437 cells/uL | 23-May-17 | $250.00 | Unknown | Yes | Genvoya | Hepatitis C | No | AIDS / HIV Seropositive (28 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063781022217DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 22-Feb-17 | Roche cobas RT-PCR | 18,610 copies/mL | 21-Feb-17 | Most Recent CD4 Results | 488 cells/uL | 21-Feb-17 | $250.00 | Unknown | No | None currently or previously | Syphilis | No | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900067816021717DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 17-Feb-17 | Roche cobas RT-PCR | 630 copies/mL | 17-Feb-17 | Most Recent CD4 Results | 1311 cells/uL | 17-Feb-17 | $250.00 | Unknown | Yes | Complera | None | No | HIV Seropositive (3 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075633030617DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 69 Y | Female | Non-Hispanic | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 75 cells/uL | 6-Mar-17 | $250.00 | Unknown | Yes | Intelence Prezista Isentress Norvir | None | No | AIDS / HIV Seropositive (22 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900355600120919D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.30 | 1.00 | $110.00 | 35 Y | Male | Non-Hispanic | <-70C | 09-Dec-19 | Roche cobas Taqman | RT-PCR | 11,890 | 2019-10-28 | Most Recent CD4 Results | 509 cells/uL | 2019-10-28 | $110.00 | Unknown | 2019-12-09 | Yes Descovy, Evotaz started 17-Apr-2017 | HIV Seropositive | Sexual Transmission | None | HIV-1 Positive 21-Dec-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900355601120919D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.40 | 1.00 | $110.00 | 28 Y | Male | Non-Hispanic | <-70C | 09-Dec-19 | Roche cobas Taqman | RT-PCR | 20 | 2019-11-05 | Most Recent CD4 Results | 582 cells/uL | 2019-11-05 | $110.00 | Unknown | 2019-12-09 | Yes Genvoya started on 5-Jun-2017 | HIV Seropositive | Sexual Transmission | Syphilis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900365818121619DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.50 | 1.00 | $110.00 | 41 Y | Male | Hispanic | <-70C | 16-Dec-19 | Roche cobas | RT-PCR | 90 | 03-Dec-19 | Most Recent CD4 Results | 228 cells/uL | 3-Dec-19 | $110.00 | Unknown | None | 2019-12-16 | Yes Triumeq started on 3-Dec-2018 | AIDS | Sexual Transmission | None | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046637032111DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 54 Y | Male | Unknown | < -70C | 21-Mar-11 | Roche Amplicor | U/A | HIV | CD4 Result | 495 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Zerit, Ziagen, Viracept | Hepatitis C, history of neurosyphilis | IV Drug Abuse | History of proteinuria & hypercholesterol, cataract surgery to right eye, HTN, uveitis, glaucoma, G6PD deficient, recurrent abcesses on face & neck | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046640032111DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 53 Y | Female | Unknown | < -70C | 21-Mar-11 | Roche Amplicor | 41 copies/mL | HIV | CD4 Result | 619 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Emtricitabine, Kaletra, Invirase | No co-infections | Unknown | Nuclear sclerotic cataract bilat, myopial presbyopia, osteopenia, hyperlipidemia, HTN, low Vitamin D, release of left trigger thumb | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046645030211DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 62 Y | Male | Unknown | < -70C | 02-Mar-11 | Roche Amplicor | 138 copies/mL | HIV | CD4 Result | 905 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Atripla Slight hemolysis on one tube | Hepatitis A + 1/8/10 | Transfusion | No Symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051111010617DD | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 54 Y | Male | Non-Hispanic | <-70C | 06-Jan-17 | Roche cobas RT-PCR | <20 copies/mL | 27-Dec-16 | Most Recent CD4 Results | 175 cells/uL | 27-Dec-16 | $250.00 | Unknown | Yes | Descovy Prezcobix | None | None | HIV Seropositive (13 years) | Sexual Transmission | ALT: 24 IU/L; AST: 29 IU/L; ALP: 96 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 1.20 mg/dL; 27-Dec-16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458834031320D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 64 Y | Male | Non-Hispanic | 13-Mar-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-03-13 | Biktarvy started in 2019 | Sexual Transmission | None | 244 cells/uL 4-Feb-2020 | Yes | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458834031320D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 64 Y | Male | Non-Hispanic | 13-Mar-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-03-13 | Biktarvy started in 2019 | Sexual Transmission | None | 244 cells/uL 4-Feb-2020 | Yes | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458835021920D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 58 Y | Male | Non-Hispanic | 19-Feb-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-02-19 | Biktarvy started in Jan-2020 | Sexual Transmission | None | 650 cells/uL 5-Feb-2020 | Yes | Norvir and Prezista ended in Jan-2020 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458835021920D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 4.00 | 1.00 | $110.00 | 58 Y | Male | Non-Hispanic | 19-Feb-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-02-19 | Biktarvy started in Jan-2020 | Sexual Transmission | None | 650 cells/uL 5-Feb-2020 | Yes | Norvir and Prezista ended in Jan-2020 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458836021720D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 66 Y | Male | Non-Hispanic | 17-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-17 | Triumeq started in 2015 | None | Hepatitis C | 812 cells/uL 10-Jan-2020 | Yes | Prezcobix, Viread ended in 2015 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458836021720D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 66 Y | Male | Non-Hispanic | 17-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-17 | Triumeq started in 2015 | Sexual Transmission | Hepatitis C | 812 cells/uL 10-Jan-2020 | Yes | Prezcobix, Viread ended in 2015 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458836021720D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 2.00 | $110.00 | 66 Y | Male | Non-Hispanic | 17-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-17 | Triumeq started in 2015 | Sexual Transmission | Hepatitis C | 812 cells/uL 10-Jan-2020 | Yes | Prezcobix, Viread ended in 2015 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458837111919D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 47 Y | Female | Non-Hispanic | 19-Nov-19 | Unknown Manufacturer | 34 copies/mL | HIV | $110.00 | Unknown | 2019-11-19 | Yes | Reactive | 12-Nov-2019 | 2nd Gen Serological HIV 1/2 Ab/Ag | 136 cells/uL | 8-Oct-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458838010620D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 4.00 | 1.00 | $110.00 | 22 Y | Female | Non-Hispanic | 06-Jan-20 | Cobas AmpliPrep Taqman | 1218 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | None currently. Will start new therapy 9-Jan-2020 but not sure which one | None | None | 258 cells/uL 17-Dec-2019 | No | Truvada, Norvir and Prezista started in 2016. History of non-compliance | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458838010620D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 4.00 | $110.00 | 22 Y | Female | Non-Hispanic | 06-Jan-20 | Cobas AmpliPrep Taqman | 1218 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | None currently. Will start new therapy 9-Jan-2020 but not sure which one | None | None | 258 cells/uL 17-Dec-2019 | No | Truvada, Norvir and Prezista started in 2016. History of non-compliance | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458839020520D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 7530 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Tivicay, Truvada and Prezcobix started in 2013 | None | None | 449 cells/uL 14-Jan-2020 | Yes | Truvada, Norvir and Prezcobix ended in 2013. | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458839020520D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 55 Y | Male | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 7530 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Tivicay, Truvada and Prezcobix started in 2013 | Sexual Transmission | None | 449 cells/uL 14-Jan-2020 | Yes | Truvada, Norvir and Prezcobix ended in 2013. | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458839020520D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 2.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 7530 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Tivicay, Truvada and Prezcobix started in 2013 | Sexual Transmission | None | 449 cells/uL 14-Jan-2020 | Yes | Truvada, Norvir and Prezcobix ended in 2013. | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458840120319D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 50 Y | Female | Non-Hispanic | 03-Dec-19 | Unknown Manufacturer | 39 copies/mL | HIV | $110.00 | Unknown | 2019-12-03 | No | N/A | N/A | N/A | 437 cells/uL | 5-Sep-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458841020420D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 1.00 | $110.00 | 43 Y | Female | Unknown | 04-Feb-20 | Unknown Manufacturer | 109009 copies/mL | HIV | $110.00 | Unknown | 2020-02-04 | Biktarvy started in Sep-2019 | Sexual Transmission | None | 104.07 cells/uL 30-Dec-2019 | Yes | No previous therapy. Patient was diagnosed in Sep-2019. | Reactive | HIV Antigen / Antibody | Unknown Manufacturer 9-Sep-2019 | HIV-1 Positive | HIV-1 Supplemental 9-Sep-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458842111919D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 56 Y | Female | Non-Hispanic | 19-Nov-19 | Roche Taqman Assay v2.0 | 82 copies/mL | HIV | $110.00 | Unknown | 2019-11-19 | No | N/A | N/A | N/A | 260.10 cells/mcL | 26-Jul-2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458843021120D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 22 Y | Male | Hispanic | 11-Feb-20 | Cobas AmpliPrep Taqman | 43862 copies/mL | HIV | $110.00 | Unknown | 2020-02-11 | Triumeq started in 2017 | None | None | 422 cells/uL 21-Jan-2020 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458843021120D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 22 Y | Male | Hispanic | 11-Feb-20 | Cobas AmpliPrep Taqman | 43862 copies/mL | HIV | $110.00 | Unknown | 2020-02-11 | Triumeq started in 2017 | Sexual Transmission | None | 422 cells/uL 21-Jan-2020 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458843021120D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 22 Y | Male | Hispanic | 11-Feb-20 | Cobas AmpliPrep Taqman | 43862 copies/mL | HIV | $110.00 | Unknown | 2020-02-11 | Triumeq started in 2017 | Sexual Transmission | None | 422 cells/uL 21-Jan-2020 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458844013020D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 30 Y | Male | Hispanic | 30-Jan-20 | Unknown Manufacturer | 56 copies/mL | HIV | $110.00 | Unknown | 2020-01-30 | Descovy & Tivicay started in Oct-2016 | None | Hepatitis C | 670 cells/uL 21-Jan-2020 | No | Norvir, Truvada & Reyataz ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458844013020D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 30 Y | Male | Hispanic | 30-Jan-20 | Unknown Manufacturer | 56 copies/mL | HIV | $110.00 | Unknown | 2020-01-30 | Descovy & Tivicay started in Oct-2016 | Sexual Transmission | Hepatitis C | 670 cells/uL 21-Jan-2020 | No | Norvir, Truvada & Reyataz ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458846010720D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 4.00 | 2.00 | $110.00 | 54 Y | Female | Non-Hispanic | 07-Jan-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-01-07 | Biktarvy started Dec-2018 | None | None | 618 cells/uL 1-Nov-2019 | No | Atripla from 2011-2018 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458846010720D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 54 Y | Female | Non-Hispanic | 07-Jan-20 | Unknown Manufacturer | 20 copies/mL | HIV | $110.00 | Unknown | 2020-01-07 | Biktarvy started Dec-2018 | None | None | 618 cells/uL 1-Nov-2019 | No | Atripla from 2011-2018 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458847120319D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 3.00 | 1.00 | $110.00 | 51 Y | Female | Hispanic | 03-Dec-19 | Unknown Manufacturer | 7550 copies/mL | HIV | $110.00 | Unknown | 2019-12-03 | Biktarvy started Jan-2017 | Joint pain | None | 722 cells/uL 27-Aug-2019 | Yes | Descovy, Sustiva and Norvir ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458847120319D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 51 Y | Female | Hispanic | 03-Dec-19 | Unknown Manufacturer | 7550 copies/mL | HIV | $110.00 | Unknown | 2019-12-03 | Biktarvy started Jan-2017 | Joint pain | None | 722 cells/uL 27-Aug-2019 | Yes | Descovy, Sustiva and Norvir ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458848012220D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 22-Jan-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-01-22 | Juluca started in 2018 | None | None | 595 cells/uL 11-Nov-2019 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458848012220D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.60 | 3.00 | $110.00 | 55 Y | Male | Non-Hispanic | 22-Jan-20 | Unknown Manufacturer | 30 copies/mL | HIV | $110.00 | Unknown | 2020-01-22 | Juluca started in 2018 | None | None | 595 cells/uL 11-Nov-2019 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458849022720D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 44 Y | Male | Hispanic | 27-Feb-20 | Unknown Manufacturer | 60 copies/mL | HIV | $110.00 | Unknown | 2020-02-27 | Biktarvy started in 2019 | None | None | 689 cells/uL 13-Feb-2020 | Yes | Complera ended in 2019; Genvoya ended in 2018; Atripla ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458849022720D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 44 Y | Male | Hispanic | 27-Feb-20 | Unknown Manufacturer | 60 copies/mL | HIV | $110.00 | Unknown | 2020-02-27 | Biktarvy started in 2019 | Sexual Transmission | None | 689 cells/uL 13-Feb-2020 | Yes | Complera ended in 2019; Genvoya ended in 2018; Atripla ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458849022720D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 44 Y | Male | Hispanic | 27-Feb-20 | Unknown Manufacturer | 60 copies/mL | HIV | $110.00 | Unknown | 2020-02-27 | Biktarvy started in 2019 | Sexual Transmission | None | 689 cells/uL 13-Feb-2020 | Yes | Complera ended in 2019; Genvoya ended in 2018; Atripla ended in 2017 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458850021220D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 63 Y | Female | Non-Hispanic | 12-Feb-20 | Unknown Manufacturer | 80 copies/mL | HIV | $110.00 | Unknown | 2020-02-12 | None | None | Hepatitis C | 1659 cells/uL 24-Jan-2020 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458850021220D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 63 Y | Female | Non-Hispanic | 12-Feb-20 | Unknown Manufacturer | 80 copies/mL | HIV | $110.00 | Unknown | 2020-02-12 | None | IV Drug Abuse | Hepatitis C | 1659 cells/uL 24-Jan-2020 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458850021220D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 63 Y | Female | Non-Hispanic | 12-Feb-20 | Unknown Manufacturer | 80 copies/mL | HIV | $110.00 | Unknown | 2020-02-12 | None | IV Drug Abuse | Hepatitis C | 1659 cells/uL 24-Jan-2020 | No | Does not recall previous therapy | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458851020520D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 62 Y | Female | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Triumeq started about 5 or 6 years ago | None | None | 594 cells/uL 23-Jan-2020 | Yes | Kaletra - Doesn't recall end date | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458851020520D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 62 Y | Female | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Triumeq started about 5 or 6 years ago | Sexual Transmission | None | 594 cells/uL 23-Jan-2020 | Yes | Kaletra - Doesn't recall end date | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458851020520D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 3.00 | 1.00 | $110.00 | 62 Y | Female | Non-Hispanic | 05-Feb-20 | Unknown Manufacturer | 100 copies/mL | HIV | $110.00 | Unknown | 2020-02-05 | Triumeq started about 5 or 6 years ago | Sexual Transmission | None | 594 cells/uL 23-Jan-2020 | Yes | Kaletra - Doesn't recall end date | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458852020620D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 06-Feb-20 | Unknown Manufacturer | 2250 copies/mL | HIV | $110.00 | Unknown | 2020-02-06 | Evotaz and Abacavir started in 2016 | None | None | 1091 cells/uL 22-Jan-2020 | Yes | Reyataz, Norvir and Epivir ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458852020620D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 4.00 | 1.00 | $110.00 | 55 Y | Male | Non-Hispanic | 06-Feb-20 | Unknown Manufacturer | 2250 copies/mL | HIV | $110.00 | Unknown | 2020-02-06 | Evotaz and Abacavir started in 2016 | Sexual Transmission | None | 1091 cells/uL 22-Jan-2020 | Yes | Reyataz, Norvir and Epivir ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458852020620D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 55 Y | Male | Non-Hispanic | 06-Feb-20 | Unknown Manufacturer | 2250 copies/mL | HIV | $110.00 | Unknown | 2020-02-06 | Evotaz and Abacavir started in 2016 | Sexual Transmission | None | 1091 cells/uL 22-Jan-2020 | Yes | Reyataz, Norvir and Epivir ended in 2016 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458853121619D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 36 Y | Female | Non-Hispanic | 16-Dec-19 | Unknown Manufacturer | 503 copies/mL | HIV | $110.00 | Unknown | 2019-12-16 | No | N/A | N/A | N/A | 613 cells/uL | 2019-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458854031120D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 4.00 | 1.00 | $110.00 | 61 Y | Male | Non-Hispanic | 11-Mar-20 | Unknown Manufacturer | 50 copies/mL | HIV | $110.00 | Unknown | 2020-03-11 | Prezcobix and Tivicay started in 2012 | None | Hepatitis C | 326 cells/uL 27-Jan-2020 | Yes | Kaletra and Truvada ended in 2012 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458854031120D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 3.00 | $110.00 | 61 Y | Male | Non-Hispanic | 11-Mar-20 | Unknown Manufacturer | 50 copies/mL | HIV | $110.00 | Unknown | 2020-03-11 | Prezcobix and Tivicay started in 2012 | Sexual Transmission | Hepatitis C | 326 cells/uL 27-Jan-2020 | Yes | Kaletra and Truvada ended in 2012 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458854031120D3 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 3.00 | 1.00 | $110.00 | 61 Y | Male | Non-Hispanic | 11-Mar-20 | Unknown Manufacturer | 50 copies/mL | HIV | $110.00 | Unknown | 2020-03-11 | Prezcobix and Tivicay started in 2012 | Sexual Transmission | Hepatitis C | 326 cells/uL 27-Jan-2020 | Yes | Kaletra and Truvada ended in 2012 | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458855121819D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 6.00 | 1.00 | $110.00 | 57 Y | Male | Non-Hispanic | 18-Dec-19 | Roche Taqman Assay v2.0 | 107 copies/mL | HIV | $110.00 | Unknown | 2019-12-18 | No | N/A | N/A | N/A | 268 cells/uL | 2019-10-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458856010620D1 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 5.00 | 1.00 | $110.00 | 18 Y | Male | Non-Hispanic | 06-Jan-20 | Unknown Manufacturer | 68200 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | Biktarvy started 22-Nov-2019 | None | None | 453 cells/uL 13-Nov-2019 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900458856010620D2 | Human immunodeficiency virus (HIV) | United States | K2 EDTA Plasma | 1.50 | 4.00 | $110.00 | 18 Y | Male | Non-Hispanic | 06-Jan-20 | Unknown Manufacturer | 68200 copies/mL | HIV | $110.00 | Unknown | 2020-01-06 | Biktarvy started 22-Nov-2019 | None | None | 453 cells/uL 13-Nov-2019 | Yes | None | N/A | N/A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900345996101719DD | Human immunodeficiency virus (HIV) | Ukraine | K3 EDTA | 1.10 | 1.00 | $100.00 | 21 Y | Male | Non-Hispanic | <-70C | 17-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 275 | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900375618101019DD | Human immunodeficiency virus (HIV) | Ukraine | K3 EDTA | 1.10 | 1.00 | $100.00 | 33 Y | Female | Non-Hispanic | <-70C | 10-Oct-19 | Abbott VL | Abbott HIV-1 | PCR | 226 | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900375620101619DD | Human immunodeficiency virus (HIV) | Ukraine | K3 EDTA | 1.20 | 1.00 | $100.00 | 26 Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 521 | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900375622101619DD | Human immunodeficiency virus (HIV) | Ukraine | K3 EDTA | 1.10 | 1.00 | $100.00 | 36 Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 54,900 | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KEA0000-AB900111874120716DD | Human immunodeficiency virus (HIV) | Uganda | 1 K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 13 Y | Male | Non-Hispanic | <-70C | 07-Dec-16 | Abbott M2000 RT-PCR | 1001 copies/mL | 7-Dec-16 | Most Recent CD4 Results | 998 cells/?L | 11-Oct-16 | 20-Feb-04 | Seropositive 13 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KEA0000-AB900111874122116DD | Human immunodeficiency virus (HIV) | Uganda | 1 K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 21-Dec-16 | Abbott M2000 RT-PCR | 1009 copies/mL | 21-Dec-16 | Most Recent CD4 Results | 509 cells/?L | 21-Dec-16 | 18-May-07 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LHP0000-AI900355223052219DD | Human immunodeficiency virus (HIV) | United States | L. Heparin Plasma | 1.10 | 1.00 | $100.00 | 28 Y | Male | Non-Hispanic | <-70C | 22-May-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RUI0000-AI900108378081318DD | Human immunodeficiency virus (HIV) | United States | Raw Urine | 3.50 | 1.00 | Special Order. Please Inquire | 50 Y | Female | Hispanic | <-70C | 13-Aug-18 | Abbott Architect | Positive | HIV | Special Order. Please Inquire | Unknown |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.